Candriam S.C.A. Mckesson Corp Transaction History

Candriam S.C.A.

$15.6 Billion
Q1 2025

A detailed history of Candriam S.C.A. transactions in Mckesson Corp stock. As of the latest transaction made, Candriam S.C.A. holds 121,403 shares of MCK stock, worth $85.6 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

121,403

Previous 106,889 13.58%

Holding current value

$85.6 Million

Previous $60.9 Million 34.12%

% of portfolio

0.53%

Previous 0.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$566.21 - $672.99 $8.22 Million - $9.77 Million	14,514 Added 13.58%	121,403 $81.7 Million
Q4 2024 Feb 06, 2025	BUY	$482.27 - $628.5 $10.3 Million - $13.5 Million	21,423 Added 25.07%	106,889 $60.9 Million
Q3 2024 Nov 13, 2024	SELL	$479.06 - $630.38 $703,260 - $925,397	-1,468 Reduced 1.69%	85,466 $42.2 Million
Q2 2024 Aug 05, 2024	SELL	$518.81 - $607.81 $13.5 Million - $15.9 Million	-26,112 Reduced 23.1%	86,934 $50.8 Million
Q1 2024 May 03, 2024	BUY	$473.42 - $539.26 $30.7 Million - $35 Million	64,874 Added 134.67%	113,046 $60.7 Million
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $4.85 Million - $5.22 Million	11,081 Added 29.88%	48,172 $22.3 Million
Q3 2023 Nov 13, 2023	BUY	$402.4 - $446.42 $12.2 Million - $13.5 Million	30,269 Added 443.7%	37,091 $16.1 Million
Q2 2023 Aug 08, 2023	SELL	$354.01 - $427.31 $2.53 Million - $3.05 Million	-7,143 Reduced 51.15%	6,822 $2.92 Million
Q1 2023 May 12, 2023	SELL	$335.35 - $386.06 $78,807 - $90,724	-235 Reduced 1.65%	13,965 $4.97 Million
Q4 2022 Feb 13, 2023	SELL	$346.68 - $397.58 $755,415 - $866,326	-2,179 Reduced 13.3%	14,200 $5.33 Million
Q3 2022 Nov 10, 2022	SELL	$321.25 - $373.84 $614,551 - $715,155	-1,913 Reduced 10.46%	16,379 $5.57 Million
Q2 2022 Aug 03, 2022	BUY	$300.57 - $336.42 $639,913 - $716,238	2,129 Added 13.17%	18,292 $5.97 Million
Q1 2022 May 13, 2022	BUY	$244.61 - $310.48 $2 Million - $2.54 Million	8,194 Added 102.82%	16,163 $4.95 Million
Q4 2021 Feb 10, 2022	SELL	$198.21 - $248.9 $111,988 - $140,628	-565 Reduced 6.62%	7,969 $1.98 Million
Q3 2021 Nov 09, 2021	SELL	$188.42 - $208.66 $215,175 - $238,289	-1,142 Reduced 11.8%	8,534 $1.7 Million
Q2 2021 Jul 20, 2021	SELL	$184.89 - $202.68 $4.73 Million - $5.19 Million	-25,599 Reduced 72.57%	9,676 $1.85 Million
Q4 2020 Jan 22, 2021	SELL	$143.79 - $183.66 $714,923 - $913,157	-4,972 Reduced 12.35%	35,275 $6.14 Million
Q3 2020 Oct 19, 2020	BUY	$140.89 - $159.9 $288,120 - $326,995	2,045 Added 5.35%	40,247 $5.99 Million
Q2 2020 Jul 23, 2020	SELL	$125.49 - $164.68 $1.36 Million - $1.79 Million	-10,855 Reduced 22.13%	38,202 $5.86 Million
Q4 2019 Jan 21, 2020	SELL	$130.23 - $153.27 $98,974 - $116,485	-760 Reduced 1.53%	49,057 $7,000
Q3 2019 Oct 21, 2019	BUY	$134.24 - $148.53 $4.85 Million - $5.37 Million	36,142 Added 264.29%	49,817 $7,000
Q2 2019 Aug 01, 2019	SELL	$112.47 - $134.93 $246,534 - $295,766	-2,192 Reduced 13.81%	13,675 $2.77 Million
Q4 2018 Feb 14, 2019	SELL	$108.23 - $136.84 $3.18 Million - $4.03 Million	-29,417 Reduced 64.96%	15,867 $1.75 Million
Q3 2018 Nov 07, 2018	BUY	$123.14 - $138.52 $3.66 Million - $4.12 Million	29,745 Added 191.42%	45,284 $6.01 Million
Q2 2018 Aug 14, 2018	BUY	$133.4 - $158.13 $176,088 - $208,731	1,320 Added 9.28%	15,539 $2.07 Million
Q1 2018 May 09, 2018	BUY	$138.75 - $176.72 $47,591 - $60,614	343 Added 2.47%	14,219 $2 Million
Q4 2017 Feb 07, 2018	SELL	$135.02 - $162.6 $2.44 Million - $2.94 Million	-18,106 Reduced 56.61%	13,876 $2.16 Million
Q3 2017 Nov 03, 2017	BUY	$146.0 - $161.87 $4.67 Million - $5.18 Million	31,982	31,982 $4.91 Million

Others Institutions Holding MCK

# of Institutions

1,954

Shares Held

112M

Call Options Held

783K

Put Options Held

773K

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $101B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account